scholarly journals Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs

2015 ◽  
Vol 67 (8) ◽  
pp. 1086-1094 ◽  
Author(s):  
Shih-Yin Chen ◽  
Chan-Bum Choi ◽  
Qian Li ◽  
Wei-Shi Yeh ◽  
Yuan-Chi Lee ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Health Care Utilization ◽  
Lupus Erythematosus ◽  
Care Utilization ◽  
Systemic Lupus

scholarly journals Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement

2013 ◽  
Vol 65 (3) ◽  
pp. 382-390 ◽  
Author(s):  
Marie Tanzer ◽  
Cheryl Tran ◽  
Kassandra L. Messer ◽  
Amber Kroeker ◽  
Emily Herreshoff ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Health Care Utilization ◽  
Children And Adolescents ◽  
Lupus Erythematosus ◽  
Care Utilization ◽  
Systemic Lupus ◽  
Kidney Involvement

scholarly journals Health care in systemic lupus erythematosus (SLE): the patient’s perspective

2014 ◽  
Vol 33 (9) ◽  
pp. 1279-1287 ◽  
Author(s):  
E. J. M. Zirkzee ◽  
G. M. Steup-Beekman ◽  
A. A. Schouffoer ◽  
S. M. Henquet ◽  
M. A. A. Caljouw ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Patient’S Perspective

scholarly journals Telerheumatology: A Narrative Review

2021 ◽  
Vol 2 (3) ◽  
pp. 139-145
Author(s):  
Wei Tang ◽  
Leila Khalili ◽  
Anca Askanase
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Clinical Trials ◽  
Lupus Erythematosus ◽  
Delivery Of Health Care ◽  
Healthcare Professionals ◽  
Direct Consequence ◽  
Systemic Lupus ◽  
Rheumatology Practice

Abstract Telemedicine (TM), the delivery of health care using telecommunication technologies, has been in use in rheumatology practice for over two decades to maximize access and optimize care. As a direct consequence of the Coronavirus disease 2019 (COVID-19) pandemic in March 2020, rheumatology practice shifted from traditional in-person encounters to TM to ensure the safety of both healthcare professionals and patients. However, there is limited literature on the acceptance, feasibility, and effectiveness of TM in the management of rheumatic diseases. Additionally, there is limited guidance on the implementation of telerheumatology (TR) for both patient care and clinical trials. Here we reviewed the most recent publications related to the application of TR, in the management of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE), assessed the perceptions of patients and physicians on TM in rheumatology, and identified several key barriers to TR.

scholarly journals Patient-reported Satisfaction with Current Clinical Management of Systemic Lupus Erythematosus in Kazakhstan

2020 ◽  
Vol 8 (E) ◽  
pp. 411-418
Author(s):  
Yeldos Khamitov ◽  
Zaituna Khismetova ◽  
Maiya Goremykina ◽  
Sandro Vento ◽  
Arkadiy Kotlyar ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Health Care ◽  
Lupus Erythematosus ◽  
Clinical Management ◽  
Multiple Logistic Regression Analysis ◽  
Health Care Facilities ◽  
Systemic Lupus ◽  
Patient Dissatisfaction ◽  
Patient Reported

BACKGROUND: Over the past decades, patient satisfaction has been increasingly recognized as a powerful tool to measure the quality of health-care services. AIM: This study evaluated the satisfaction of systemic lupus erythematosus (SLE) patients with current clinical management in Semey, East Kazakhstan, and explored the factors associated with dissatisfaction. METHODS: All adult SLE patients registered at health-care facilities of Semey were enrolled in a cross-sectional study. RESULTS: Out of 67 patients, 66 were females and their mean age was 39 years. Symptoms associated with the musculoskeletal system were the most commonly reported (95.5%), followed by fatigue (88.1%) and neurological symptoms (53.7%). None of the patients were very satisfied or satisfied with current clinical management and the overall rate of patient dissatisfaction was 83.6%. Education (p = 0.04), monthly income (p = 0.01), SLE disease activity index score (p = 0.031), therapy with biologic agents (p = 0.029), immunosuppressants (p = 0.01), and corticosteroids (p = 0.01) were predictors of patient dissatisfaction in multiple logistic regression analysis. CONCLUSION: This real-world study is the first effort to understand the experience of SLE patients within the health-care system of Kazakhstan and the results may facilitate doctor-patient discussions on the initiatives that need to be taken to improve the quality of the medical services provided.

Sign in / Sign up

Export Citation Format

Share Document